Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
60.4100 +0.2700    +0.45%
16:35:51 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 787
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 59.9200 - 60.5800
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
WKN:  885823
Gilead 60.4100 +0.2700 +0.45%
Time Frame:
11/07/2022 - 09/08/2022
 
Date Price Open High Low Vol. Change %
Aug 09, 2022 60.4100 60.5000 60.5200 59.9200 0.79K 0.45%
Aug 08, 2022 60.1400 60.2100 60.3800 59.5200 0.80K 0.02%
Aug 05, 2022 60.1300 60.3200 60.8800 59.8500 0.64K -1.09%
Aug 04, 2022 60.7900 60.7000 61.5400 60.6900 2.88K -2.61%
Aug 03, 2022 62.4200 59.8100 62.6000 59.1000 5.99K 6.17%
Aug 02, 2022 58.7900 58.4400 58.8300 57.8500 2.65K 0.94%
Aug 01, 2022 58.2400 58.2900 58.4900 58.0600 0.57K -0.50%
Jul 29, 2022 58.5300 58.8300 59.3300 58.5300 1.97K -1.38%
Jul 28, 2022 59.3500 59.0500 60.0000 59.0500 1.74K -0.17%
Jul 27, 2022 59.4500 60.6200 60.6200 59.2400 1.72K -0.82%
Jul 26, 2022 59.9400 59.7500 60.1900 59.5000 0.48K 0.99%
Jul 25, 2022 59.3500 59.5600 60.2700 59.2400 2.39K -0.70%
Jul 22, 2022 59.7700 59.8500 60.4200 59.7500 1.18K -0.76%
Jul 21, 2022 60.2300 60.7200 60.7200 59.6800 0.73K -0.43%
Jul 20, 2022 60.4900 60.9500 60.9500 60.2000 0.57K -0.10%
Jul 19, 2022 60.5500 60.6300 60.6300 59.4600 1.25K -0.57%
Jul 18, 2022 60.9000 62.4900 62.4900 60.7300 1.11K -1.39%
Jul 15, 2022 61.7600 62.0900 62.0900 60.8000 2.39K 0.59%
Jul 14, 2022 61.4000 62.0000 62.0000 61.4000 1.01K -0.36%
Jul 13, 2022 61.6200 62.0900 62.1000 61.6200 0.36K -1.03%
Jul 12, 2022 62.2600 62.5900 62.5900 61.9200 2.39K 0.11%
Jul 11, 2022 62.1900 61.7000 62.6000 61.7000 2.57K 0.23%
Highest: 62.6000 Lowest: 57.8500 Difference: 4.7500 Average: 60.3959 Change %: -2.6430
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email